CompaniesDigestome Therapeutics

Digestome Therapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

68

By Phase

PHASE1: 1

By Status

COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
Today
NCT05121831
Hover over trial bars to see details

Recent Trials

NCT05121831Lead Sponsor
A First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of DGX-001
PHASE1Completed
68 participants
Started: Feb 24, 2022 · Completed: Nov 6, 2022